Lidocaine for systemic sclerosis: a double-blind randomized clinical trial

Table 2 Intra-observer variation for modified Rodnan skin score

	n	Mean	Median	SD	Lower Value	Higher Value	P value *
RSS- m 1a	24	18,33	19	8,07	3	33	0,588
RSS-m 1b	24	18,21	17,5	8,17	3	33
RSS-m 2a	24	13,29	13,5	6,4	2	30	0,257
SCR-m 2b	24	13,46	13,5	6,33	2	30
RSS-m 3a	24	13,5	13,5	7,25	2	30	0,266
RSS-m 3b	24	13,38	13,5	7,29	2	30

* T Student test
RSS-m 1a: modified Rodnan skin score - before treatment at moment 1; RSS-m 1b: modified Rodnan skin score - before treatment at moment 2; RSS-m 2a: modified Rodnan skin score - immediately after treatment at moment 1; RSS-m 2b: modified Rodnan skin score - immediately after treatment at moment 2; RSS-m 3a: modified Rodnan skin score - after 6-months follow-up at moment 1; RSS-m 3b: modified Rodnan skin score - after 6-months follow-up at moment 2; SD: standard deviation.

ISSN: 1750-1172